Bayer employee donations doubled for Haiti Disaster Fund

The company, which has pledged to double any money donated by its employees, will therefore make this upto £4,000. These funds are to be used for projects that will make a sustainable contribution to reconstruction in the disaster areas.

Martin Dawkins, managing director for Bayer UK and Ireland, comments: “It’s fantastic to see how our employees have pulled together and contributed to this worthy cause. It goes to show how we uphold the company values of respect for people and nature.”

On January 18th, Bayer responded to the Red Cross appeal by providing relief in the form of medicines worth around £79,000 (EUR 90,000). Bayer is not directly affected by the earthquake in Haiti as it does not have any employees or offices in the Latin American country.

Rachel Owen,

Phone: 01635 563410,

Fax: 01635 563513

E-mail: rachel.owen.ro@bayer.co.uk

Andrea Postles,

Phone: 01635 563031,

Fax: 01635 563513

E-mail: andrea.postles.ap@bayer.co.uk

Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. The company’s products and services are designed to benefit people and improve their quality of life. At the same time Bayer creates value through innovation, growth and high earning power. The Group is committed to the principles of sustainable development and to its role as a socially and ethically responsible corporate citizen. Economy, ecology and social responsibility are corporate policy objectives of equal rank. In fiscal 2008, Bayer employed 108,600 people and had sales of €32.9 billion. Capital expenditures amounted to €2.0 billion, R&D expenses to €2.7 billion. For more information, go to www.bayer.com.

For news releases, background material and graphics on Bayer worldwide, go to www.press.bayer.com

Forward-Looking Statements

This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.